Recent Recap for Week Ending 11/17
Executives
- A new compensation rule could cause difficulties for CEOs
- Johnson & Johnson Wades Into Death Penalty Debate For First Time
- Why Early Peeks at Drug Trials Are Giving Investors Whiplash
Lawyers, Regulatory and Compliance
- Sued for Retweeting – Yes, That Just Happened
- When do you use conventional versus digital inspection methods?
- A law professor’s big idea for combatting greedy drug company titans like Martin Shkreli
- FDA finalizes guidance on medical device interoperability
- Live from FDA/PDA: 3D Printing Applications, FDA releases statement
Promotional
- Lying Opioid pharma representative causes deaths
- A Cancer Conundrum: Too Many Drug Trials, Too Few Patients
- Novartis trial marks ResearchKit first in MS
Pricing, Reimbursement and Medical Affairs
- Express Scripts says new payment model needed for promising, but costly gene therapies
- Gamification of medical education: Choose Your Own Medventure
- An Easy Way to Cut Drug Costs
Clinical Trials
- Safety monitoring oversight adds value to your study
- Real World Evidence: FDA Commits to Advancing its Use
Manufacturing
- FDA to Fund Manufacturing Research Programs at NIPTE
- FDA teams with medical companies in Puerto Rico to tackle shortages
- Guidance: Post-Complete Response Letter Meetings Between FDA and ANDA Applicants Under GDUFA
Pharmacy
- Pharmacists partner with doctors, not just pushing pills
- Former Monongahela pharmacist gets probation in drug-smuggling case
- U.S. Attorney Charges Pharmacy Tech for Tampering with Opioids
Medical Marijuana
- School Announces Bid to Test Medical Marijuana
- Medical Marijuana Company Requests Re-Vote From Town
- Pennsylvanians getting mixed messages about medical marijuana program
Privacy and Cybersecurity
- Smiths Medical could have a cybersecurity problem
- Why Cybersecurity Must be Part of Medical Device Architecture
- Why This Cybersecurity Expert Wants You Rethink What You Keep Secret
Futurism
- Left to Their Own Devices: The Promise and Dangers of IoT-Connected Medical Devices
- How Diseases Can Be Targeted Using Nanotechnology – And Why It’s Difficult
- Make way for the cyborg – why humans could be unrecognisable in the future
Food
- The ABCs of GMO Disclosure in the United States
- There’s More Evidence That The “Organic” Label Is Meaningless
- Dairy farmers address fear-based food labeling in campaign
Cosmetics
- More FDA regulations of cosmetics will not make them safer
- FDA Sets the Limits on Lead in Lipstick, Other Cosmetics
- The FDA Needs More Power to Regulate Toxic Chemicals in Cosmetics
Patient Advocacy
- Statement by FDA Commissioner Scott Gottlieb, M.D. on new steps by FDA to advance patient engagement in the agency’s regulatory work
- Startups Are Turning Customers into Lobbyists
- FDA discusses patient advocacy
Bioethics
- A Plutocratic Proposal: an ethical way for rich patients to pay for a place on a clinical trial
- A quiet revolution in organ transplant ethics
- An anarchist takes on the drug industry — by teaching patients to make their own meds
Recent Comments